Lake Shore Gazette

Leading News Website

Medicinal Cannabis Compounding Market To Grow On A Non-Gullible Note

Cannabis is safer and has less severe side effects in comparison to other treatment options. It also finds usage along with other treatments either to enhance their efficacy or to combat adverse side effects. For instance, it is very effective in reducing nausea and increasing appetite among chemotherapy patients.

Similarly, it is also used in combination with traditional opioid painkillers, which enables patients to reduce the dosage and frequency of opioids significantly and imparts greater pain relief. Many countries in Europe have legalized cannabis thus it can be used for medicinal purpose, such as Italy, Germany.

Get Sample Copy of this Report@

The increasing adoption of cannabis for medicinal purpose due to its lesser side effects will increase its legalization in countries still banned. Increase in R&D and technical innovations have shown the benefits of cannabis extracts to be helpful in many diseases.There is still plenty of scope for research in effectiveness of cannabis. As cannabis extracts act as body’s own chemicals its effectiveness increases with lesser side effects.

Cannabis is legal in Europe which makes it yet another region for high growth for medicinal cannabis compounding market. There has been increasing R&D in the region and adoption of various treatment options making it lucrative for the market growth.Request for Table of Content@

Suitable government policies and regulations for the reimbursement of digital health applications are expected to boost the European medicinal cannabis compounding market over forecast years

Some of the key players of Medicinal Cannabis Compounding include,

  • Aphria Inc.
  • Aurora Cannabis
  • Cannabis Science Inc.
  • Canopy Growth Corporation
  • Medical Marijuana Inc.
  • VIVO Cannabis Inc.
  • TikunOlam Ltd
  • Terra Tech Corp.
  • Tilray and Cronos Group
  • Harvest Health & Recreation
  • Green Thumb Industries
  • Maricann Group Inc.
  • TerrAscend
  • Others.

Companies offering Medicinal Cannabis Compounding are involved in existing product upgrades, new product launches, mergers and acquisitions, and regional expansion to enhance their market position.

Access Full Report@

Key Segments

By Product Type

  • Extracts
  • Flowers
  • Leaves
  • Others

By Application

  • Tetrahydrocannabinol
  • Cannabidiol
  • Others

By End User

  • Hospitals
  • Clinics
  • Research Institutes
  • Others

About Us:

Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers’ experience by acting as the “missing” link between “customer relationships” and “business outcomes’. The best possible returns are assured therein.

Contact Us:

Persistence Market Research
Address – 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales –
Website –

Leave a Reply

Your email address will not be published. Required fields are marked *